Abstract
The review discusses the biosafety issues related to the rapid development of molecular medicine and biotechnology. On an example
of the USA data on efficiency of the accepted legislative base on restriction of dual use technologies, and also efficiency of the international
legislative initiatives in the mentioned area are provided. Materials of the researches which have been published in leading natural science
periodicals and have caused in scientific community the sharpest discussion from positions of biological safety are considered.
Authors and affiliations
A.L. Kovtun, D.L. Poklonsky
State Budgetary Educational Institution of Higher Professional Education «I.M. Sechenov First Moscow State
Medical University» of the Ministry of Health care and Social Development, Moscow, Russian Federation